BACKGROUND
Argyrolobium roseum is described in texts for its botanical aspects with no mention of its therapeutic uses. Recently, a solvent fraction of this plant has been reported to possess insulin secretagogue activity.
OBJECTIVE
Primary objective of the study was to evaluate the hypoglycemic